Efficacy of spironolactone in reducing the risk of cardiovascular events and long-term mortality in those with resistant hypertension: findings from the Anglo-Scandinavian Cardiac Outcomes Trial.
Event: ESC Congress 2025
Topic: Pharmacotherapy
Session: New insights into antihypertensive treatment
